2018 JSCO临床实践指南:儿童,青少年以及青年癌症患者生育能力保留

2018-03-26 日本临床肿瘤学会 Int J Clin Oncol. 2018 Mar 26.

最近几年,得益于肿瘤治疗的进展越来越的的肿瘤患者可达到长期生存,但是肿瘤治疗科导致性腺功能减退进而丧失生育能力。因此,临床肿瘤医生考虑儿童,青少年以及青年癌症患者生育能力保留问题非常重要。本文回顾了世界范围内最新的信息和临床指南,提出了儿童,青少年以及青年癌症患者生育能力保留的一般原则和建议。

中文标题:

2018 JSCO临床实践指南:儿童,青少年以及青年癌症患者生育能力保留

英文标题:

Clinical Practice Guidelines for Fertility Preservation in Pediatric, Adolescent, and Young Adults with Cancer.

发布机构:

日本临床肿瘤学会

发布日期:

2018-03-26

简要介绍:

最近几年,得益于肿瘤治疗的进展越来越的的肿瘤患者可达到长期生存,但是肿瘤治疗科导致性腺功能减退进而丧失生育能力。因此,临床肿瘤医生考虑儿童,青少年以及青年癌症患者生育能力保留问题非常重要。本文回顾了世界范围内最新的信息和临床指南,提出了儿童,青少年以及青年癌症患者生育能力保留的一般原则和建议。

 

拓展指南:生育相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2018 JSCO临床实践指南:儿童,青少年以及青年癌症患者生育能力保留)] GetToolGuiderByIdResponse(projectId=1, id=a353f1c0015ea266, title=2018 JSCO临床实践指南:儿童,青少年以及青年癌症患者生育能力保留, enTitle=Clinical Practice Guidelines for Fertility Preservation in Pediatric, Adolescent, and Young Adults with Cancer., guiderFrom=Int J Clin Oncol. 2018 Mar 26., authorId=null, author=, summary=最近几年,得益于肿瘤治疗的进展越来越的的肿瘤患者可达到长期生存,但是肿瘤治疗科导致性腺功能减退进而丧失生育能力。因此,临床肿瘤医生考虑儿童,青少年以及青年癌症患者生育能力保留问题非常重要。本文回顾了世界范围内最新的信息和临床指南,提出了儿童,青少年以及青年癌症患者生育能力保留的一般原则和建议。 , cover=, journalId=null, articlesId=null, associationId=1621, associationName=日本临床肿瘤学会, associationIntro=, copyright=0, guiderPublishedTime=Mon Mar 26 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<P>最近几年,得益于肿瘤治疗的进展越来越的的肿瘤患者可达到长期生存,但是肿瘤治疗科导致性腺功能减退进而丧失生育能力。因此,临床肿瘤医生考虑儿童,青少年以及青年癌症患者生育能力保留问题非常重要。本文回顾了世界范围内最新的信息和临床指南,提出了儿童,青少年以及青年癌症患者生育能力保留的一般原则和建议。 </P> <P> </P>拓展指南:<STRONG>与<FONT color=red>生育</FONT>相关指南:</STRONG><BR> <UL> <LI><A title="2018 临床实践指南:青春期后女性癌症患者生育能力保留" target=_blank href="http://www.medsci.cn/guideline/show_article.do?id=fffaa1c001552527">2018 临床实践指南:青春期后女性癌症患者生育能力保留</A> <LI><A title="2017 EAPM建议:早产和生育管理" target=_blank href="http://www.medsci.cn/guideline/show_article.do?id=8c4f01c001a31e5b">2017 EAPM建议:早产和生育管理</A> <LI><A title="2016 ASRM指南:生育药物与癌症" target=_blank href="http://www.medsci.cn/guideline/show_article.do?id=6deef1c001266679">2016 ASRM指南:生育药物与癌症</A> <LI><A title="2016 SOGC加拿大女性营养共识:青春期、生育期、绝经期及绝经后期" target=_blank href="http://www.medsci.cn/guideline/show_article.do?id=4b91e1c001265348">2016 SOGC加拿大女性营养共识:青春期、生育期、绝经期及绝经后期</A> <LI><A title="2016 EULAR循证建议:系统性红斑狼疮和/或抗磷脂综合征女性患者计划生育,辅助生殖,妊娠和更年期管理及健康" target=_blank href="http://www.medsci.cn/guideline/show_article.do?id=6a9d61c0012a9579">2016 EULAR循证建议:系统性红斑狼疮和/或抗磷脂综合征女性患者计划生育,辅助生殖,妊娠和更年期管理及健康</A> 更多信息请点击:<A target=_blank href="http://www.medsci.cn/guideline/list.do?q=%E7%94%9F%E8%82%B2">有关生育更多指南</A></LI></UL>, tagList=[TagDto(tagId=2813, tagName=癌症患者), TagDto(tagId=69703, tagName=生育能力保留)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=4, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5118, appHits=78, showAppHits=0, pcHits=3983, showPcHits=1536, likes=118, shares=2, comments=9, approvalStatus=1, publishedTime=Sat Mar 31 20:23:47 CST 2018, publishedTimeString=2018-03-26, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sat Mar 31 20:23:47 CST 2018, updatedBy=null, updatedName=null, updatedTime=Fri Jan 05 09:23:08 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 JSCO临床实践指南:儿童,青少年以及青年癌症患者生育能力保留)])
2018 JSCO临床实践指南:儿童,青少年以及青年癌症患者生育能力保留
下载请点击:
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=302340, encodeId=aa533023400f, content=学习并分享!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Tue Apr 03 09:14:30 CST 2018, time=2018-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=301720, encodeId=f842301e20bd, content=希望有机会看到更多类似的经验分享.这样可以让非一线临床工作人员.但又从事该方面工作的人员提供一个直观的解析., beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Sun Apr 01 09:59:14 CST 2018, time=2018-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=301708, encodeId=92a7301e089d, content=学习谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Sun Apr 01 09:18:28 CST 2018, time=2018-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=301687, encodeId=eed930168e45, content=阅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Sun Apr 01 08:45:25 CST 2018, time=2018-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=301663, encodeId=6fa9301663be, content=了解了解.学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Sun Apr 01 08:14:05 CST 2018, time=2018-04-01, status=1, ipAttribution=)]
    2018-04-03 大爰

    学习并分享!!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=302340, encodeId=aa533023400f, content=学习并分享!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Tue Apr 03 09:14:30 CST 2018, time=2018-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=301720, encodeId=f842301e20bd, content=希望有机会看到更多类似的经验分享.这样可以让非一线临床工作人员.但又从事该方面工作的人员提供一个直观的解析., beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Sun Apr 01 09:59:14 CST 2018, time=2018-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=301708, encodeId=92a7301e089d, content=学习谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Sun Apr 01 09:18:28 CST 2018, time=2018-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=301687, encodeId=eed930168e45, content=阅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Sun Apr 01 08:45:25 CST 2018, time=2018-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=301663, encodeId=6fa9301663be, content=了解了解.学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Sun Apr 01 08:14:05 CST 2018, time=2018-04-01, status=1, ipAttribution=)]
    2018-04-01 虈亣靌

    希望有机会看到更多类似的经验分享.这样可以让非一线临床工作人员.但又从事该方面工作的人员提供一个直观的解析.

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=302340, encodeId=aa533023400f, content=学习并分享!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Tue Apr 03 09:14:30 CST 2018, time=2018-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=301720, encodeId=f842301e20bd, content=希望有机会看到更多类似的经验分享.这样可以让非一线临床工作人员.但又从事该方面工作的人员提供一个直观的解析., beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Sun Apr 01 09:59:14 CST 2018, time=2018-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=301708, encodeId=92a7301e089d, content=学习谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Sun Apr 01 09:18:28 CST 2018, time=2018-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=301687, encodeId=eed930168e45, content=阅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Sun Apr 01 08:45:25 CST 2018, time=2018-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=301663, encodeId=6fa9301663be, content=了解了解.学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Sun Apr 01 08:14:05 CST 2018, time=2018-04-01, status=1, ipAttribution=)]
    2018-04-01 龙胆草

    学习谢谢分享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=302340, encodeId=aa533023400f, content=学习并分享!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Tue Apr 03 09:14:30 CST 2018, time=2018-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=301720, encodeId=f842301e20bd, content=希望有机会看到更多类似的经验分享.这样可以让非一线临床工作人员.但又从事该方面工作的人员提供一个直观的解析., beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Sun Apr 01 09:59:14 CST 2018, time=2018-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=301708, encodeId=92a7301e089d, content=学习谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Sun Apr 01 09:18:28 CST 2018, time=2018-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=301687, encodeId=eed930168e45, content=阅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Sun Apr 01 08:45:25 CST 2018, time=2018-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=301663, encodeId=6fa9301663be, content=了解了解.学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Sun Apr 01 08:14:05 CST 2018, time=2018-04-01, status=1, ipAttribution=)]
    2018-04-01 神功盖世

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=302340, encodeId=aa533023400f, content=学习并分享!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Tue Apr 03 09:14:30 CST 2018, time=2018-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=301720, encodeId=f842301e20bd, content=希望有机会看到更多类似的经验分享.这样可以让非一线临床工作人员.但又从事该方面工作的人员提供一个直观的解析., beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Sun Apr 01 09:59:14 CST 2018, time=2018-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=301708, encodeId=92a7301e089d, content=学习谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Sun Apr 01 09:18:28 CST 2018, time=2018-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=301687, encodeId=eed930168e45, content=阅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Sun Apr 01 08:45:25 CST 2018, time=2018-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=301663, encodeId=6fa9301663be, content=了解了解.学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Sun Apr 01 08:14:05 CST 2018, time=2018-04-01, status=1, ipAttribution=)]
    2018-04-01 1dd8c52fm63(暂无匿称)

    了解了解.学习学习

    0